Sélectionner une page

A day in the life of InnoSer senior research associate Sarah Aerts.

PDX/O senior research associate
January 19, 2021
Sarah Interview

Afin de proposer une gamme d’outils innovants destinés à accélérer le développement de médicaments, InnoSer rassemble des professionnels issus aussi bien du monde scientifique que du monde des affaires. Grâce à notre série d’entretiens« Une journée dans la vie de… », découvrons ensemble ce que signifie faire partie de cette petite équipe polyvalente et dynamique !

Éducation

BSc Biotechnology (specialty cell & gene technology)

Basée à

Diepenbeek
Labs

Boîte à outils

Cell culture, animal models, imaging

}

Chez InnoSer depuis

January
2020

This month, our Senior Research Associate Sarah completes her first year at InnoSer. Her main focus has been on the PDX/O project: a platform that combines patient derived xenografts (PDX), and patient derived organoids (PDO) for preclinical research services. As the names tell, the platform is based on samples collected from cancer patients, paving the way for personalized medicine.

“I love my current role working with the PDX/O platform. It involves a lot of different tasks, which makes it all a fun challenge. New ideas and experiments keep each day interesting!” says Sarah. Since her work combines in vitro and in vivo methods, she keeps herself busy either in the cell culture labs or in the animal facility in Diepenbeek, located at BioVille. “Although COVID-19 had some impact on sample collection from patients at the hospital, we kept everything up and running and expect to make the project a success within the original timeframe.”

Sarah’s workday starts with driving to BioVille, or at occasional summer weekends, with a bike ride. “I come into the office and check my e-mails. After that, I usually have my to-do list for that day so I either move to the in vivo or in vitro lab.” In vitro work mostly entails expanding (growing) cells in a 3D culture. Sarah checks them daily under the microscope to know exactly which cultures are doing well. Similarly, she keeps a close eye on the PDX mice. “I weigh them and check the growth of implants weekly.” Thanks to InnoSer’s new in vivo imaging equipment, Sarah can start doing this by collecting visual readouts.

Organoids

Organoids under the microscope.

Some days, Sarah remains in the office to analyze the data on our PDX/O projects, write reports or update project records. “PDX/O is a very interesting project. Quality is very important and every little thing needs to be properly documented.” The team tries to discover as much as they can about each tumor. They analyze the tumor DNA and morphology by using sequencing, imaging, and histological methods. With this work, they both develop a well-validated model and offer clients research services.

Sarah in vitro lab

Sarah at the in vitro lab.

“What I like a lot is that we are a strong team with lots of different characters and different ideas. We think together and do our utmost to make InnoSer a success story.” Sarah says she has a ‘we can do this’ mentality, which works very well at InnoSer’s collaborative environment. “Every person in this team is equally important, that’s the atmosphere created here. The management believes in its employees. I was also really eager to grow and already on my first day here, a whole new skill box opened for me, with still more to discover and master!” Despite differences in their schedules, the team also gets together around 10am for a coffee break and around 1pm for lunch.

“I usually check the in vitro lab before I go home. Are the blinds down? Is everything shut down? Is the lab tidy enough?” Sarah advises with a smile on her face: “Don’t leave a mess behind when Laura and I are around!” After leaving InnoSer’s facilities, Sarah usually drives directly to her sports club. “I do crossfit at 2 different places so I need to make sure I have enough energy left to survive another hour of intensive sports. And that brings me to the end of my day.”

About Sarah

Sarah studied Agro and Biotechnology in the Cell and Gene Technology department of Hogeschool PXL, where she also received Environmental Coordinator degree. Her first experience at Tigenix, a cell therapy company, taught her many skills and allowed her to acquire a FELASA (laboratory animal science) certificate. She then spent almost 11 years at Apitope, a then newly started clinical stage biotech, where she worked on various in vivo and in vitro experiments, became Apitope’s biosafety and prevention officer, and implemented a quality system using her knowledge in quality assurance. Supported by InnoSer, Sarah is currently following the quality management program at the KULeuven, with direct implementations to InnoSer’s quality management system updates.

Partagez cet article sur les réseaux sociaux ! [DISPLAY_ULTIMATE_SOCIAL_ICONS]

Articles récents

Le volume rénal total (TKV) : un indicateur non invasif de l'évolution de la maladie, pertinent sur le plan translationnel

Le volume rénal total (TKV) : un indicateur non invasif de l'évolution de la maladie, pertinent sur le plan translationnel

Dans la newsletter de ce mois-ci, nous vous invitons à découvrir comment l'évaluation longitudinale du volume rénal total (TKV) réalisée par InnoSer à l'aide d'une imagerie échographique non invasive sur notre modèle murin de PKD autosomique dominante fournit des données structurelles en phase avec la pratique clinique, qui facilitent directement la prise de décision dans...

En savoir plus
Panels de biomarqueurs cliniquement pertinents pour des études d'efficacité exhaustives sur des modèles murins de la maladie d'Alzheimer

Panels de biomarqueurs cliniquement pertinents pour des études d'efficacité exhaustives sur des modèles murins de la maladie d'Alzheimer

Les modèles murins validés d'InnoSer pour la maladie d'Alzheimer (MA) intègrent des panels de biomarqueurs pertinents sur le plan translationnel — couvrant les espèces de bêta-amyloïde (Aβ), les isoformes phosphorylées de la protéine Tau, ainsi que le marqueur précoce et sensible de la neurodégénérescence que constituent les neurofilaments légers...

En savoir plus

Toutes les catégories

Soyez les premiers informés : recevez ces actualités directement dans votre boîte mail

InnoSer propose toute une gamme de plateformes validées in vitro et in vivo permettant le développement efficace de nouveaux traitements. Si vous souhaitez obtenir des informations complémentaires, n'hésitez pas à nous contacter ; nous vous répondrons dans les jours qui suivent.

Nous publions chaque mois une lettre d'information de nos laboratoires InnoSer, qui présente des informations scientifiques sur nos services de recherche. Pour recevoir ces actualités directement dans votre boîte mail, inscrivez-vous ici.